According to researchers, pregabalin is more effective and cost-effective in neuropathic pain management compared to gabapentin. This drug offers better analgesia with fewer adverse effects and better compliance. A recent study published in the journal Cureus by Riya K. and colleagues indicates that pregabalin offers superior clinical and economic outcomes and has the potential to be a first-line treatment for neuropathic pain, especially in resource-constrained healthcare settings.

In neuropathic conditions, gabapentinoids are a drug class generally used for their role in modulating calcium channels and reducing neurotransmitter release; examples include gabapentin and pregabalin. However, it has remained uncertain which one gives better therapeutic value, especially when cost has to b

See Full Page